To the full analysis
Vivendi stock: growth
VIV.PAVivendi reported $340.19M in revenue for fiscal 2025, up 3.4% on the prior year.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
−19.7%
per year from 2006 to 2025, per share −18.9%
Earnings (Annual rate)
−24.4%
per year from 2006 to 2025, per share −23.7%
Free cash flow (Annual rate)
−23.2%
per year from 2006 to 2025, per share −22.5%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | −54.7% | −29.9% | −19.7% |
| Revenue per share | −53.4% | −27.7% | −18.9% |
| Earnings | −57.5% | −36.7% | −24.4% |
| Earnings per share | −56.3% | −34.7% | −23.7% |
| Free cash flow | −53.0% | no data | −23.2% |
| Free cash flow per share | −51.7% | no data | −22.5% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $22.21B | $4.47B | $3.03B |
| 2007 | $24B | $4.18B | $3.82B |
| 2008 | $28.14B | $2.88B | $4.03B |
| 2009 | $30.06B | $919.72M | $5.21B |
| 2010 | $32B | $2.44B | $3.91B |
| 2011 | $31.93B | $2.97B | $3.87B |
| 2012 | $32.13B | $198.35M | $2.87B |
| 2013 | $24.53B | $2.18B | $2.84B |
| 2014 | $11.18B | $5.26B | $3.71B |
| 2015 | $11.93B | $2.14B | −$7.76M |
| 2016 | $11.99B | $1.39B | $468.73M |
| 2017 | $13.79B | $1.35B | $1.58B |
| 2018 | $15.44B | $140.73M | $926.37M |
| 2019 | $17.62B | $1.75B | $947.43M |
| 2020 | $17.83B | $1.6B | $873.18M |
| 2021 | $10.61B | −$596.16M | $1.3B |
| 2022 | $10.63B | −$716.94M | $402.24M |
| 2023 | $11.65B | $448.78M | $605.02M |
| 2024 | $329.11M | −$6.65B | $2.04B |
| 2025 | $340.19M | $22.16M | $19.95M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 21 Nov 2025)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.